Lv1
41 积分 2025-04-16 加入
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
1个月前
已完结
Deep-learning analysis of 3D microarchitectural remodeling in hypertrophic cardiomyopathy
1个月前
已完结
Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
1个月前
已完结
A phase III study of combination therapy with everolimus plus lanreotide versus everolimus monotherapy for unresectable or recurrent gastroenteropancreatic neuroendocrine tumor (JCOG1901, STARTER-NET)
1个月前
已完结
Surufatinib combined with sintilimab and IBI310 for the treatment of high‐grade advanced‐neuroendocrine neoplasms: A single arm, open‐label, single‐center, phase II study
1个月前
已完结
1705O LITESPARK-015: Belzutifan in advanced pheochromocytoma and paraganglioma
1个月前
已完结
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p)
1个月前
已完结
Alkylating agent rechallenge in metastatic pancreatic neuroendocrine tumors
1个月前
已完结
Molecular Pathology of Soft-tissue Neoplasms
1个月前
已关闭
皖公网安备34019202002308
